Neuroendocrine tumors of the gastroenteropancreatic system: I. Diagnostic advances

Oncology Research and Treatment

Volumn 19, Issue 2, 1996, Pages 119-124

  Scherubl H ^a   Faiss, S ^a   Zimmer, T ^a   Riecken, E O ^a   Wiedenmann, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endosonography; Multiple endocrine neoplasia 1; Neuroendocrine gastroenteropancreatic tumors; Somatostatin receptor scintigraphy

Indexed keywords

SOMATOSTATIN RECEPTOR;

GASTROINTESTINAL TRACT; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS; REVIEW; SCINTISCANNING;

EID: 0029953140     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218777     Document Type: Article

References (54)

1. Vinik AI, McLeod MK, Shapiro B, Lloyd RV, Cho K: Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989:18:865-896.
2. Basser RL, Green MD: Recent advances in carcinoids and gastrointestinal neuroendocrine tumors. Curr Opin Oncol 1991:3:109-120.
3. Öberg K: Chemotherapy and biotherapy in neuroendocrine tumors. Curr Opin Oncol 1993:5:110-120.
4. Norton JA: Endocrine tumors of the pancreas Introduction. World J Surg 1993:17:425-426.
5. Norton JA: Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 1994:31:90-156.
6. Moertel CG: An odyssey in the land of small tumors. J Clin Oncol 1987:5:1502-1522.
7. Vinik AI, Thompson N, Echkauser F, Mottari AR: Clinical features of carcinoid syndrome and the use of somatostatin analogue and its management. Acta Oncol 1989:28:389-402.
8. Wiedenmann B, Scherübl H, John M, Zimmer T, Ahnert-Hilger G, Riecken EO: Molekular- und zellbiologische Aspekte neuroendokriner Tumorerkrankungen des gastroenteropankrcatischen Systems: in Beger HG. Manns M, Greten M (Hrsg): Molekularbiologische Grundlagen der Gastroenterologie. Berlin, Springer, 1995. pp 42-61.
9. Ahnert-Hilger G, Scherübl H, Riecken EO, Wiedenmann B: Classification of neuroendocrine cells: in Scherübl II. Hescheler J (eds): The Electrophysi-ology of Neuroendocrine Cells. Boca Raton. CRC Press. 1995. pp 11-23.
10. Skogseid B, Rastad J, Öberg K: Multiple endocrine neoplasia type I, Endocrinol Metab Clin North Am 1994:23:1-18.
11. Vassilopoulou-Sellin R, Ajani J: Islet cell tumours of the pancreas. Endocrinol Metab Clin North Am 1994:23:53-67.
12. Skogseid B, Eriksson B, Lundqvist G, Lorelius LE, Rastad J, Wide L, Wilander E, Akerström G, Öberg K: Multiple endocrine neoplasia type I: A ten year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991:73:281-287.
13. Donow C, Pipeleers-Marichal M, Schröder S, Stamm B, Heitz P, Klöppel G: Surgical pathology of gastrinoma: Site. size, multicentricity, association with multiple endocrine neoplasia type 1. and malignancy. Cancer 1991:68:1329-1334.
14. Pipeleers-Marichal M, Donow C, Heitz PU, Klöppel G: Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I, World J Surg 1993:17:481-488.
15. Eriksson B, Karnberg H, Lindgren PG, Lörelius LE, Magnusson A, Lundqvist G, Skogseid B, Wide L, Wilander E, Öberg K: Neuroendocrine pancreatic tumors: Clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med 1990:228:103-113.
16. Eriksson B, Öberg K: An update of the medical treatment of malignant endocrine pancreatic tumors. Acta Oncol 1993:32:203-208.
17. Mignon M, Rusziniewski P, Posevin P, Sabbagh L, Cadiot G, Rigaud D, Bonfils S: Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type 1. World J Surg 1993:17:489-497.
18. Ruszniewski P, Podevin P, Cadiot G, Marmuse JP, Mignon M, Vissuzaine C, Bonfils S, Lehy T: Clinical, anatomical, and evolutive features of patients with Zollinger-Ellison syndrome combined with multiple endocrine neoplasia. Pancreas 1993:8:295-304.
19. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Or-bueh M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA, Jensen RT: Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study. Gastroenterology 1995:108:1637-1649.
20. Scherübl H, Bredeek U, Öberg K, Ouabbe HJ, Riecken EO, Wiedenmann B: Association of neuroendocrine gastroenteropancreatic tumor disease with multiple endocrine neoplasia type 1. Gastroenterology 1995:108(suppl): A535.
21. Larsson C, Weber G, Teh BT, Lagercrantz J: Genetics of mulitple endocrine neoplasia type 1. Ann NY Acad Sci 1994:733:453-463.
22. Raue F, Scherübl H: Karzinomfrühdiagnose durch genetische Marker. Dtsch Ärztebl 1995:92:773-774.
23. Cryer PE: Glucose homeostasis and hypoglycemia: in Wilson JD. Foster DW (eds): Williams Textbook of Endocrinology. Philadelphia. Saunders. 1992. pp 1223-1255.
24. Service FJ: Hypoglycemic disorders. N Engl J Med 1995:332:1144-1152.
25. Andersen DK: Current diagnosis and management of Zollinger-Ellison syndrome. Ann Surg 1989:210: 685-703.
26. Zimmer T, Stölzel U, Bader M, Fett U, Foss HD, Riecken EO, Rehfeld JF, Wiedenmann B: A duodenal gastrinoma in a patient with diarrhoea and normal serum gastrin concentrations. N Engl J Med 1995:333:334-336.
27. McCiuigan JE: The Zollinger Ellison syndrome: in Sleisenger MH. Fordtran JS (eds): Gastrointestinal disease: 4th ed. Philadelphia. Saunders. 1989. pp 909-925.
28. Deftos U: Chromogranin A: Its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocrine Rev 1991:12:181-187.
29. Bender H, Maier A, Wiedenmann B, O'Connor DT, Messner K, Schmidt-Gayk H: Immunoluminometric assay of chromogranin A in serum with commercially available reagents. Clin Chem 1992:38: 2267-2272.
30. Rösch T, Lightdale CJ, Botel JF, Boyce GA, Sivak MV, Yasuda K, Hevder N, Palazzo L, Danevgier H, Schusdziarra V, Classen M: Localisation of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992:326:1721-1726.
31. Zimmer T, Ziegler K, Bäder M, Fett U, Hamm KB, Riecken EO, Wiedenmann B: Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut 1994:35:471-475.
32. Zimmer T, Ziegler K, Lichr KM, Stölzel U, Riecken EO, Wiedenmann B: Endo-sonography of neuroendocrine tumors of the stomach, duodenum, and pancreas. Ann NY Acad Sei 1994:733:425-437.
33. Zimmer T, Stölzel U, Liehr RM, Bäder M, Fett U, Hamm B, Wiedemnann B, Riecken EO: Somatostatinrezeptor-Szintigraphie und endoskopischer Ultraschall zur Diagnostik von Insulinomen und Gastrinomen. Dtsch Med Wochenschr 1995:120:87-93.
34. Krenning EP, Bakker WH, Breeman WA, et al.: Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin, Lancet 1989;i:242-244.
35. Lamberts SW, Bakker WH, Krenning EP: Somatostalin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990:323:1246-1249.
36. Lamberts SWJ, Hofland LJ, van Koetsfeld PM, Reubi JC, Bruining HA, Bakker WH, Krenning EP: Parallel in vitro and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab 1990:71:566-574.
37. Lamberts SWJ, Krenning EP, Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 1991;12:450-482.
38. Lamberts SWJ, Chayaviallc JA, Krenning EP: The visualization of gastrocntero-pancreatic endocrine tumors. Metabolism 1992:41:111-115.
39. Lamberts SW, Reubi JC, Krenning EP: Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors. Acta Oncol 1993:32: 167-170.
40. Krenning EP, Kwekkeboom DJ, Lei H Y, De Jong RJ, Dop FJ, Reubi JC, Lamberts SW: Somatostatin-receptor scintigraphy in gastrocnteropancreatic tumors: An overview of European results. Ann NY Acad Sei 1994:733:416-425.
41. Reubi JC, Kvols L, Krenning E, Lamberts SW: In vitro and in vivo detection of somatostatin receptors in human malignant tissues. Acta Oncol 1991:30:463-468.
42. Scherübl H, John M, Meyerhoff W, Reubi JC, Hescheler J, Bychkov R, Riecken EO, Wiedenmann B: Somatostatin receptor-subtypes in neuroendocrine gastroen-teropancreatic cells: in Singer M V, Ziegler R, Rohr G (eds): Gastrointestinal tract and endocrine system. Dordrecht. Kluwer Acad. Publ, 1995. pp 438-441.
43. John M, Meyerhof W, Richter D, Waser B, Schaer JC, Scherübl H, Boese-Land-graf J, Neuhaus P, Riecken EO, Reubi JC, Wiedenmann B: Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor sub-type 2. Gut 1996:38:33-39.
44. Scherübl H, Bäder M, Fett U, Hamni B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riecken EO, Wiedenmann B: Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology 1993:105:1705-1709.
45. Scherübl H, Riecken EO, Wiedemnann B: Somatostatin-receptor scintigraphy in endocrine tumors. Gastroenterology 1994:106:1724.
46. Kvols LK, Brown ML, O’Connor MK, Hung JC, Hayostek RJ, Reubi JC, Lamberts SWJ: Evaluation of a radiolabeled somatostatin analog (1-123 Octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology 1993:187:129-133.
47. Wiedenmann B, Bäder M, Scherübl H, Fett U, Zimmer T, Hamni B, Koppenhagen K, Riecken EO: Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. Semin Oncol 1994:21:29-32.
48. Eriksson B, Bergström M, Lilja A, Ahlström H, Langström B, Öberg K: Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. Acta Oncol 1993;32:189-196.
49. Eriksson B, Lilja A, Ahlström H, Bjurling M, Lindner KJ, Langström B, Öberg K: Positron-emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors. Ann NY Acad Sci 1994;733:437-446.
50. Iniamura M, Takahashi K: Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison Syndrome. World J Surg 1993:17: 433-438.
51. Doppnian JL, Miller DL, Chang R, Gorden P, Eastman RC, Norton JA: Intraartc-rial calcium stimulation test for detection of insulinomas. World J Surg 1993; 17:439-443.
52. Pellika PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pilot HC, Kvols LK: Carcinoid heart disease: Clinical and echocardiographic spectrum in 74 patients. Circulation 1993:87:1188-1196.
53. Dingerkus H, Völler H, Schröder K, Dißmann R, Henning L, Agrawal R, Linderer T, Wiedenmann B: Endokardfibrose bei neuroendokrinen Tumoren des gastroenteropankreatischen Systems. Dtsch Med Wochenschr 1994:119:647-652.
54. Klöppel G, Heitz PU: Morphological and functional activity of gastroenteropan-creatic neuroendocrine tumours. Recent Results Cancer Res 1990:118:27-36.